FIM
UTHR icon

Freedom Investment Management’s United Therapeutics UTHR Stock Holding History

Freedom Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-735
Closed -$211K – 684
2025
Q2 		$211K Sell
735
-164
-18% -$49K 0.02% 694
2025
Q1 		$277K Buy
899
+30
+3% +$10.3K 0.02% 616
2024
Q4 		$307K Buy
869
+53
+6% +$19.5K 0.03% 588
2024
Q3 		$292K Buy
816
+3
+0.4% +$1.01K 0.02% 606
2024
Q2 		$259K Sell
813
-271
-25% -$71.7K 0.02% 654
2024
Q1 		$249K Sell
1,084
-90
-8% -$20.3K 0.02% 668
2023
Q4 		$258K Sell
1,174
-100
-8% -$23K 0.02% 639
2023
Q3 		$288K Sell
1,274
-131
-9% -$30.2K 0.04% 521
2023
Q2 		$310K Sell
1,405
-333
-19% -$73.8K 0.03% 533
2023
Q1 		$389K Sell
1,738
-793
-31% -$195K 0.04% 478
2022
Q4 		$704K Sell
2,531
-163
-6% -$41.1K 0.08% 320
2022
Q3 		$564K Buy
2,694
+113
+4% +$25.3K 0.07% 382
2022
Q2 		$608K Sell
2,581
-661
-20% -$134K 0.06% 380
2022
Q1 		$582K Buy
3,242
+1,341
+71% +$255K 0.05% 430
2021
Q4 		$411K Sell
1,901
-92
-5% -$18.1K 0.03% 586
2021
Q3 		$368K Sell
1,993
-1,400
-41% -$276K 0.03% 591
2021
Q2 		$609K Sell
3,393
-395
-10% -$75.2K 0.05% 479
2021
Q1 		$634K Sell
3,788
-661
-15% -$110K 0.05% 445
2020
Q4 		$675K Buy
+4,449
New +$584K 0.07% 260
2019
Q2 		– Sell
-2,970
Closed -$349K – 735
2019
Q1 		$349K Buy
+2,970
New +$346K 0.03% 473
2018
Q1 		– Sell
-2,875
Closed -$425K – 1206
2017
Q4 		$425K Buy
+2,875
New +$365K 0.02% 706
2016
Q3 		– Sell
-2,394
Closed -$254K – 947
2016
Q2 		$254K Buy
+2,394
New +$267K 0.02% 655

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Freedom Investment Management's UTHR Position: Q3 2025 in Review

Freedom Investment Management sold out of United Therapeutics (UTHR) in Q3 2025, closing a stake of 735 shares — an estimated $211K sold.

Freedom Investment Management first reported a position in UTHR in Q2 2016 and held it in 22 quarters. The position peaked at $704K in Q4 2022. 708 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • Freedom Investment Management reported no remaining United Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Freedom Investment Management sold 735 United Therapeutics shares in Q3 2025, an estimated $211K.
  • Freedom Investment Management first reported a position in United Therapeutics in Q2 2016 and held it in 22 quarters.
  • Freedom Investment Management's United Therapeutics position peaked at $704K in Q4 2022.
  • 708 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Freedom Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.